التفاصيل البيبلوغرافية
العنوان: |
LBA3 Compartmental radioimmunotherapy (cRIT) 131I-OMBURTAMAB in patients with neuroblastoma (NB) central nervous system (CNS) and/or leptomeningeal (LM) metastases: Updated results from pivotal Trial 101 |
المؤلفون: |
Basu, E., Mora, J., Streby, K., Bear, M., Sano, H., Marachelian, A., Harrison, D., Nysom, K., Pandit-Taskar, N., Zanzonico, P., Fabricius, S., During, M., Nielsen, J.R., Kramer, K. |
المصدر: |
In Immuno-Oncology and Technology December 2022 16 Supplement 1 |
قاعدة البيانات: |
ScienceDirect |